Acadia Pharmaceuticals Inc.的动态

Today, Acadia Pharmaceuticals and Saniona announced initial positive results from ACP-711 (formerly SAN711) Phase 1 Study. Read more here: https://bit.ly/41hDojc

  • 该图片无替代文字
Robert McSweeny

Senior Neurology Account Manager- Rare Disease-Epilepsy - Multiple Presidents Club winning Sales Professional with a wide array of disease state knowledge and extensive launch experience.

1 天前

Fantastic news!

赞
回复
Drew Rennie

Director Client Solutions | Life Science Industry Expert

2 天前

Congrats Acadia!

赞
回复
Jennifer Chastain MSN, RN

Pharma and Biotech Partner Prelaunch to Exclusivity. Understanding Your Challenges and Providing Solutions. Delivering Best Outsourced Medical and Sales Teams in Industry. Director, Client Partnerships.

2 天前

Congrats!

赞
回复
查看更多评论

要查看或添加评论，请登录

Acadia Pharmaceuticals Inc.

85,968 位关注者